. Various studies have been performed to assess the genetic, biochemical, and morphological components that contribute to PAH. Despite major advances in the understanding of the pathogenesis of PAH, the molecular mechanism(s) by which PAH promotes RVH and cardiac failure still remains elusive. Of all the mechanisms involved in the pathogenesis, inflammation and oxidative stress remain the core of the etiology of PAH that leads to development of RVH (Dorfmüller P, Perros F, Balabanian K, Humbert M. Eur Respir J 22: 358-363, 2003).
IB␣; pulmonary arterial hypertension; inflammation; cell signaling NF-⌲B IS A KEY REGULATOR OF inflammation and oxidative stress and directly modulates both redox and inflammatory signaling (40, 41) , transforming growth factor (TGF)-␤ signaling (50) , SMAD signaling (26) , Notch signaling (8) , and MAPK (56) . However, the role of NF-B in the setting of PAH-induced right ventricular (RV) hypertrophy (RVH) remains undetermined. One report (17) showed that inhibition of NF-B by pyrrolidine dithiocarbamate restored endothelial cell membrane integrity in PAH, suggesting that NF-B signaling has a vital role in the onset and progression of PAH. Since pyrrolidine dithiocarbamate is a known NF-B inhibitor as well as a potent antioxidant, it has some off-target effects, such as antioxidant activity, which might contribute to its protective mechanism. Therefore, the contribution of NF-B in the protection from PAH and RVH is not clear. To specifically elucidate a role of NF-B in RVH, induced by PAH, we used a transgenic mouse overexpressing a cardiac-specific dominant-negative IB␣ gene (3M). This transgene contains mutations at three sites that prevent IB␣ phosphorylation and degradation from the complex and thereby inhibit NF-B activation.
We hypothesized that despite the presence of underlying PAH, inhibiting NF-B activation in the heart would prevent development of RVH in these animals. We investigated the effect of cardiac specific inhibition of NF-B in RVH in a monocrotaline (MCT)-induced PAH mouse model. MCT, a plant alkaloid, is commonly used to experimentally induce PAH, which ultimately leads to RVH (43) . We chose this experimental model because MCT induces inflammation and endothelial injury leading to vascular remodeling and PAH in rodents within 3-4 wk that resemble PAH in humans (13, 48, 54) . Our observations and analyses are restricted to RV modeling in a period of 2 mo induced by PAH. This is the first report that demonstrates the role of NF-B in PAH-induced RVH in a genetically modified IB␣ mutant mouse model.
MATERIALS AND METHODS
Generation of transgenic mice overexpressing the IB␣ triple mutant gene in the heart. Generation of the cardiac specific dominantnegative IB␣ triple mutant mice (3M) has been previously described (6) . Age-and sex-matched wild-type (WT) mice of FVB background served as controls. Twelve-week-old male mice (ϳ25 g body wt) were used for experiments. The studies were conducted with the approval of Institutional Animal Care and Use Committee at the Texas A&M Health Science Center and Scott &White Hospital.
Induction of pulmonary arterial hypertension. Monocrotaline (Sigma, St. Louis, MO) powder was dissolved in 0.1 N HCl, and the pH adjusted to 7.4 with 0.1 N NaOH and filtered sterilized using a 0.22-mm disc filter. PAH was induced by a single intraperitoneal injection of MCT (60 mg/kg body wt) in 3M transgenic mice (3M-MCT) and wild-type mice (WT-MCT). Vehicle (PBS)-injected WT and 3M transgenic mice served as controls. There were a total of six mice in each group (WT, 3M, WT-MCT, and 3M-MCT). All mice were fed standard rodent chow and provided water ad libitum. It usually takes 1 mo for induction of PAH in MCT-injected animal (13, 48) , and further deterioration of PAH to RVH takes another month in our experimental model; it was for this reason, we allowed 2 mo for induction of RVH in our experimental system.
Determination of RV pressure and RVH. MCT induced eccentric RVH, which was confirmed using transthoracic echocardiography on anesthetized mice, as previously described, using a VisualSonic Vevo 2100 echocardiograph and a 35-MHz probe (5) . Briefly, mice were anesthetized with 3.5% isoflurane and subsequently maintained on 1.5% isoflurane during the procedure to maintain the heart rate between 450 and 500 beats per minute. The heart was imaged in the two-dimensional parasternal short-axis view, and the echocardiogram of the mid ventricle was recorded in all groups as previously described (14) . Also, the RV hemodynamics was determined using iWorks System, pressure catheter (CATH-SCI-1200). The catheter was inserted in the right jugular vein and was advanced into the RV and pulmonary artery. The RV pressure and hemodynamic measurements were recorded using iWorks Software (iWorx IX/228S Data Acquisition System with the Scisense Advantage pV control unit version 5.0). After completion of the procedure, animals were killed and hearts rapidly excised and flushed with PBS to remove blood. Hearts were then weighed and either snapped frozen in liquid nitrogen and stored at Ϫ80°C for isolation of RNA and proteins or stored in 10% buffered formalin for immunohistofluorescence and hematoxylin and eosin staining.
Morphological examination. MCT-induced PAH causes gross morphological alterations and changes in cardiac tissue morphology. We compared the cardiac histopathology by examining the hematoxylin and eosin (H&E)-stained sections. The sections were examined by bright-field microscopy using an Olympus microscope (Olympus, Tokyo, Japan) and photographed using a DP-72 color camera. Finally, histological sections were stained with wheat germ agglutinin-tetramethylrhodamine isothiocyanate to determine the measurement of cross-sectional areas. Morphological changes (i.e., myocyte crosssectional area and longitudinal dimension) were measured by fluorescence staining of the RV sections from each experimental group as described previously (46) . Fluorescence-tagged wheat germ agglutinin was employed because it binds to saccharides of cellular membranes (51) and has been used by other investigators for the measurement of myocyte cross-sectional area (10, 47) . Images of cardiomyocyte cell membranes were captured digitally and analyzed using the free software ImageJ from the National Institutes of Health.
RNA extraction and RT-PCR. RNA was extracted from the lung tissue and the RV tissue of WT, 3M, WT-MCT, and 3M-MCT mice using an RNEasy kit (Qiagen, Valencia, CA), following the manufacturer's instructions. For real-time RT-PCR, 500 ng to 1 g of total RNA were reverse transcribed to cDNA, using a high-capacity cDNA synthesis kit (Applied Biosystems, Foster City, CA) following the manufacturer's protocol. Gene expression changes for selected candidate genes for the bone morphogenetic protein (BMP) family (BMP-2, BMPR2, and BMPR1A), notch family (Notch-1 and Notch-3), SMAD family (SMAD 2, SMAD 4, SMAD 7, and SMAD 8), Id family (Id1, Id2, and Id3), apoptotic family (Bax, Bcl2, and caspase-3), cytokines and chemokines [ICAM-1, VCAM-1, platelet endothelial cell adhesion modecule (PECAM), CXCL2, and regulated on activation normal T-expressed and presumably secreted (RANTES)] were observed using gene-specific primers and SYBR green master mix. Quantitative RT-PCR and data analyses were performed, as described previously (21) .
NF-B RT 2 PCR array and data processing. To study the holistic effect of the dominant negative triple mutation of IB␣ on NF-B signaling in PAH-induced RVH, we performed the NF-B RT 2 PCR array (cat no. PAMM 025; SA Biosciences, Fredericks, MD), which consisted of 84 genes, including the following categories: ligands, receptors, kinases, acute response genes, inflammatory response genes, and other transcription factors responsive during the activation of NF-B signaling (Supplemental Table S1 ; Supplemental Material for this article is available online at the Am J Physiol Heart Circ Physiol website). Briefly, RNA samples isolated from the RVs of WT, WT-MCT, 3M, and 3M-MCT mice (n ϭ 3) were processed for the mouse NF-B RT 2 PCR array, as described previously (21) . Gene Network Central Pro available on http://gncpro.sabiosciences.com/ gncpro/gncpro.php was used to map the association of differentially regulated genes from the NF-B array (25) . The complete genomic sequences for these genes, available at the NCBI server, were scanned for the putative NF-B binding site(s) in their promoter region using TESS and TRANSFAC 7.0 platform (30, 45) .
Immunohistofluorescence staining. Tissue specimens were fixed in neutral buffered formalin and embedded in paraffin, and 5-m sections were mounted on glass slides. Immunohistofluorescence was performed with modifications, as previously described (31) . Briefly, sections were deparaffinized in xylene and hydrated through standard graded ethanol, in 0.1 M TBS, for 5 min. To block nonspecific binding, sections were incubated in 1% BSA and 10% normal serum in TBS. Sections were incubated overnight with a 1:50 dilution of primary anti-mouse p65 antibody (Santa Cruz) in a humidified chamber. Sections were then washed three times with TBS containing 0.1% Triton X-100 for 3 min and incubated with highly cross-adsorbed Hilyte Fluor 488-labeled goat anti mouse IgG antibody (AnaSpec, San Jose, CA), at a dilution of 1:500, for 1 h. After the sections were incubated with secondary antibody, they were washed three times with TBS and mounted using anti-fade mounting medium (Invitrogen, Carlsbad, CA), containing DAPI to label nuclei. Photomicrographs were taken using a fluorescence microscope (Olympus, Tokyo, Japan). All sections were examined and at least three to five images from each section were acquired.
Western blot analysis. RV heart tissue and lung tissue were pulverized in liquid nitrogen and cytosolic, and nuclear proteins were extracted using NE-PER nuclear and cytosolic extraction reagents (Pierce, Rockford, IL). Western blotting and subsequent quantification of each blot was performed, as described previously (21) . The primary antibodies used in this study include Id1, Notch3, Tgf-␤, SMAD-2, Bmpr2, NF-B p65 subunit, ICAM-1, and histone H4 (all from Santa Cruz Biotechnologies, Santa Cruz, CA) and GAPDH, Bcl2, and Bax (Cell Signaling Technologies, Danvers, MA).
Multiple cytokine ELISA array. Multiple inflammatory markers were detected using multi-analyte ELISArray kit (SA Biosciences) according to the manufacturer's instructions. The cytokines represented by these arrays include the following: proinflammatory cytokines IL-1␤, IL-6, IL-10, RANTES, and IFN␥. Antigen standards and positive and negative controls were also included in each kit. The opitical density was measured at 450-nm absorbance with a 570-nm correction wavelength. For each antigen, we subtracted the observed absorbance by the absorbance of the negative control to obtain corrected absorbance values. The optical denisty was normalized per milligram of protein and the fold change in cytokine levels was obtained.
Statistical analysis. All experiments were performed at least three times for each determination. Data are expressed as the means Ϯ SE and were analyzed using one-way ANOVA and secondary analysis for significance with Newman-Keuls Multiple comparison test, using Prism 5.0 GraphPad software (GraphPad, San Diego, CA). A P value Ͻ0.05 was considered statistically significant. PCR array data were analyzed using a Student's t-test.
RESULTS
MCT treatment alters the gene and protein expression in the lungs of WT and 3M mice. To determine the cell signaling molecules altered due to MCT-induced PAH in WT and 3M mice, mice were challenged with MCT and the expression of Id-BMP-Smad-Notch signaling axis molecules was determined in the lung tissue of all the animals. Our results showed that MCT treatment significantly induced the upregulation of Notch-3 and ICAM-1 mRNA by 2.8-and 2.9-fold (P Ͻ 0.05), respectively, and downregulation of Id-1, Id-3, SMAD-2, and BMPR2 by 2.6-, 2.3-, 7.7-, and 6-fold (P Ͻ 0.05), respectively, compared with untreated WT mice (Fig. 1, A and D) . At the protein level, MCT treatment upregulates Notch, ICAM-1, and Bax by 1.7-, 2.2-, and 1.3-fold (P Ͻ 0.05), respectively, and downregulates Id-1, Id-3, and BMPR2 by 2.3-, 1.8-, and 1.4-fold (P Ͻ 0.05), respectively, in WT mice. We also observed in the 3M-MCT group a significant upregulation of Notch-3, ICAM-1, and Bax by 1.5-(P Ͻ 0.05), 2.2-, and 1.3-fold (P Ͻ 0.05), respectively and downregulation of Id-1, Id-3, and BMPR2 by 2.5-fold (P Ͻ 0.05), 1.7-fold (P Ͻ 0.05), and 1.5-fold (P Ͻ 0.05), respectively ( Fig. 1, B and C). The quantification of each family member protein is shown in Fig. 1 , E and F. Together, our data indicate that MCT-induced PAH alters gene and protein expression of Id-BMP-Smad-Notch signaling axes, in the lung tissue of both WT and 3M mice.
MCT-induced RVH is prevented in 3M mice. RVH was determined by echocardiography by measuring the RV area and septum and wall thickness. MCT injection in WT mice resulted in a significant increase in chamber size of the RV, as indicated by the end-diastolic dimension and end-systolic dimension ( Fig. 2A) . The increases in both end-diastolic dimension and end-systolic dimension in MCT-treated 3M mice were significantly blunted compared with MCT-treated WT mice. There was a significant increase in the RV wall thickness to left ventricular wall ϩ septum thickness (RV/LV ϩ IVS) ratio in the MCT-treated WT group (0.50 Ϯ 0.05; P Ͻ 0.05), compared with the nontreated WT (0.35 Ϯ 0.03) or 3M group (0.35 Ϯ 0.03). Additionally, we observed that the heart weight-to-body weight ratio was increased in WT-MCT mice, which was prevented in 3M-MCT mice ( Table 1 ). The MCT-treated 3M group showed an RV mass (LV mass ϩ S) ratio of 0.38 Ϯ 0.03, which was significantly reduced, compared with the MCT-treated WT group (Fig. 2J) . The pulmonary valve outflow tract measurements showed a decrease in the velocitytime integral peak velocity in animals treated with MCT, compared with the untreated WT, which was significantly blunted in 3M mice treated with MCT. Measurement of mitral valve velocities (E and A waves) showed that the E/A ratio significantly decreased in the WT-MCT-treated group, compared with the nontreated group. The decrease in the E/A ratio was significantly less in MCT-treated 3M mice, compared with the MCT-treated WT group. The decrease in LV E/A ratio has been associated with pulmonary hypertension. The decrease in E/A by MCT treatment was significantly prevented in 3M mice. These observations corroborated the RV pressure data (Fig. 2I) . LV function and cardiac contractility, represented by ejection fraction and fractional shortening, showed no significant alteration across the treatment groups (Fig. 2, G and H) . Additionally, the RV systolic pressure showed that there was a
Id1
Id3 Notch 3 Table 1 . H&E-stained sections of the above mice hearts were examined at low (ϫ10) and high magnifications (ϫ40). Hearts from MCT-treated animals showed hypertrophied myocytes with an increase in the cross-sectional area and an increase in number of nuclei per field in the RV, compared with the untreated WT group. These maladaptive changes were restored in the 3M-MCT group (Fig. 2K, top) . WGA staining showed a significant increase in myocytes cross-sectional area in MCT-treated WT mice (11,449.33 Ϯ 2.92 vs. 4,107.58 Ϯ 3.8; P Ͻ 0.05). The MCT-induced cardiomyocyte hypertrophy was significantly reduced in 3M-MCT mice (4,336.5 Ϯ 1.12 vs. 11,449.33; P Ͻ 0.05; Fig. 2L ). The representative images from the WGA staining of hearts from WT, WT-MCT, 3M, and 3M-MCT depicting the effect of MCT treatment on cardiomyocyte crosssectional area are shown in Fig. 2K , bottom. These findings indicate that MCT-induced RVH was prevented in the 3M mice at functional as well as morphological levels.
MCT treatment activates NF-B expression in the heart. Quantitative RT-PCR showed upregulation of the NF-B-p65 gene (4.6 Ϯ 0.9-fold; P Ͻ 0.05) in the RV of WT-MCT mice, compared with the untreated WT mice (Fig. 3A) . Compared with WT-MCT mice, 3M-MCT mice showed only 2.1 Ϯ 0.3-fold increase in p65 expression, which was significantly lower than the WT-MCT group (Fig. 3A) . Both the 3M and WT groups did not show any significant upregulation of the NF-B-p65 gene (Fig. 3A) . Western blot and immunohistofluorescence analysis revealed robust translocation of NF-B-p65 protein to the nucleus in WT-MCT mice, which was prevented in 3M-MCT mice (Fig. 3, B and C) . Both cytoplasmic and nuclear proteins were verified by GAPDH and histone proteins, respectively (Fig. 3C) . The normalized relative translocation of NF-B p65 from cytosolic fraction to nuclear fraction has been represented in the Fig. 3D . Collectively, these results indicate that MCT treatment enhances and activates NF-B in the myocardium, which was prevented in the 3M-MCT mice.
Analysis of NF-B target genes by RT 2 PCR array in the RV. To gain further insight into the NF-B-target genes, we performed an quantitative RT-PCR array. MCT treatment in the WT group resulted in upregulation of the following genes: TNF, Irak1, Stat1, Tgfbr1, IB␣, IKK␤, Casp1, Rel, Egr1, NF-B1, Tgfbr2, Rela, IFN-␥, Ccl2, Fasl, IL-1␤, IL-6, and Fadd and downregulation of Bcl3, Akt1, Atf2, IKK␤, and Atf1.
The data showed that key NF-B family genes were endogenously downregulated in the RV of 3M mice, compared with WT mice. In the case of 3M-MCT mice, these genes were either not activated or their expression remained lower, compared with the WT-MCT group, indicating that these NF-Btargeted genes may have a critical role in RVH. A complete list of the differentially regulated genes in the NF-B family across the RV tissue of WT, 3M, WT-MCT, and 3M-MCT mice has been tabulated in Supplemental Table S1 . These findings indicate that NF-B associated proinflammatory and proapoptotic genes were upregulated while NF-B regulated antiapoptotic genes were downregulated.
MCT treatment alters the expression of notch and apoptotic family genes. MCT treatment increased the expression of the Notch-3 gene in WT mice by 7.2 Ϯ 0.1-fold (P Ͻ 0.05), Values are means Ϯ SE. WT, wild type; 3M, dominant-negative IB␣ triple mutant mice; MCT, monocrotaline; ESD, end-systolic dimension; EDD, enddiastolic dimension; PVOT, pulmonary valve outflow tract; E/A, E wave-to-A wave ratio; EF, ejection fraction; FS, fractional shortening; HW/BW, heart weight-to-body weight ratio; RV, right ventricular. *P Ͻ 0.05, compared with the WT group. †P Ͻ 0.05, compared with the WT-MCT group. compared with untreated WT counterpart. The 3M-MCT mice showed downregulation of the Notch-3 gene by 34.1 Ϯ 2.3-fold (P Ͻ 0.05), compared with WT-MCT mice (Fig. 4A) . Interestingly, Notch-3 was downregulated in 3M mice by 3.2 Ϯ 0.7-fold (P Ͻ 0.05), compared with WT mice (Fig. 4A) . A representative Western blot analysis revealed a 3.4 Ϯ 0.45-fold (P Ͻ 0.05) upregulation of ICD Notch-3 protein in WT-MCT mice, compared with WT mice. The ICD Notch-3 was downregulated by 4.2 Ϯ 0.65-fold (P Ͻ 0.05) in 3M-MCT group, compared with the WT-MCT group (Fig. 4, B and C) . Expression of antiapoptotic gene Bcl 2 was downregulated by 4.4 Ϯ 2.8-fold (P Ͻ 0.05) in WT-MCT mice, compared with the WT mice. The expression of Bcl 2 was increased by 11.4 Ϯ 2.1-fold (P Ͻ 0.05) in 3M-MCT mice, compared with the WT-MCT mice, indicating the restoration of Bcl 2 mRNA expression. Expression of the proapoptotic genes like caspase-3 and Bax was increased by 3.5 Ϯ 0.4 and 4.2 Ϯ 1.1-fold, (P Ͻ 0.05), respectively, in WT-MCT mice, compared with WT mice. Interestingly, the expression of Bax and caspase-3 was reduced in 3M-MCT mice by 2.9 Ϯ 0.8 and 2.37 Ϯ 0.5-fold, P Ͻ 0.05, respectively, compared with WT-MCT mice (Fig. 4D) . A representative Western blot showed upregulation of Bax and downregulation of Bcl 2 in WT-MCT group (Fig. 4E) . The Bax/Bcl 2 ratio (indicator of apoptosis) was increased by 4.43 Ϯ 0.77 (P Ͻ 0.05) in WT-MCT mice, compared with WT but was reduced in the 3M-MCT mice by representative image at high magnification (ϫ40) showing nuclear staining by DAPI (blue) and NF-B p65 subunit staining using goat anti-mouse IgG HiLyte Fluor-488 labeled (green) and colocalization of the NF-B p65 subunit in the nuclei (aqua/turquoise staining) in the transverse sections of mouse hearts. High-magnification images from the transverse sections of mouse hearts reveal that colocalization of NF-B p65 subunit was clearly observed in the nuclei of MCT-treated WT group but not in 3M and 3M-MCT groups. C: Western blots showing activation of NF-B and translocation into the nucleus. Nuclear and cytoplasmic proteins were extracted from the right ventricles of hearts from different treatment groups and Western blots performed using NF-B p65 antibody, as a probe. Representative Western blots showing activation of the NF-B p65 subunit in the cytoplasmic fraction and translocation into the nucleus. GAPDH and Histone H4 served as internal loading controls for the cytoplasmic and nuclear fractions, respectively. Data are expressed as the means Ϯ SE (n ϭ 5). *P Ͻ 0.05, compared with the WT group. #P Ͻ 0.05, compared with WT-MCT group. D: graph shows normalized relative nuclear translocation of NF-B p65 from the cytosolic fraction. Densitometry for the Western blots was performed and data was normalized with expression of GAPDH and Histone H4. Relative fold change in the WT group was set as 1. Data are expressed as the means Ϯ SE (n ϭ 4). *P Ͻ 0.05, compared with the WT group. #P Ͻ 0.05, compared with WT-MCT group.
3.2 Ϯ 0.62-fold (P Ͻ 0.05), compared with the WT-MCT mice (Fig. 4F) .
MCT treatment alters the expression of SMAD, BMP, and Id family genes. Since the BMP signaling is adversely affected under PAH, we studied the effect of MCT treatment on WT and 3M mice. MCT treatment in the WT mice resulted in dysregulated expression of SMADs, BMP, and Id family genes. Out of the four different members of SMAD family, the mRNA expression of SMAD-2 and SMAD-8 was reduced by 4.4 Ϯ 0.5-and 21.0 Ϯ 2.7-fold (P Ͻ 0.05), respectively, in the RV of WT-MCT mice, compared with WT mice. The reduction of SMAD-2 and SMAD-8 was restored in 3M-MCT mice (2.8 Ϯ 0.7-vs. 13.3 Ϯ 0.9-fold reduction, P Ͻ 0.05, compared with WT-MCT mice). The expression of SMAD-4 increased by 18.2 Ϯ 0.9-fold (P Ͻ 0.05) in WT-MCT mice and was reduced by 17.8 Ϯ 1.6-fold (P Ͻ 0.05) in the 3M-MCT mice (Fig. 5A) . A representative Western blot analysis for SMAD-2 showed downregulation of SMAD-2 (2.9 Ϯ 0.5-fold; P Ͻ 0.05) expression in the WT-MCT group (Fig. 5B) , which was restored in 3M-MCT mice (3.1 Ϯ 0.6-fold; P Ͻ 0.05; Fig. 5, B  and C) .
The mRNA expression of the BMPR2 and BMR1B genes was markedly reduced by 23.9 Ϯ 2.1-and 19.1 Ϯ 1.7-fold (P Ͻ 0.05), respectively, in the RV of WT-MCT mice, compared with the WT mice. The reduction of these genes was restored in 3M-MCT mice (18.6 Ϯ 2.3-and 14.2 Ϯ 1.1-fold, P Ͻ 0.05), compared with WT-MCT group (Fig. 5D) . The mRNA expression of the ligand BMP-2 gene was reduced in WT-MCT mice by 2.7 Ϯ 0.15-fold, in the 3M mice by 2.5 Ϯ 0.2-fold and in the 3M-MCT mice by 3.6 Ϯ 0.4-fold, compared with the untreated WT group, indicating that inhibition of NF-B was able to restore expression of BMPR2 and BMPR1A but did not affect expression of the ligand BMP-2 (Fig. 5D) . A representative Western blot analysis for BMPR2 showed downregulation of BMPR2 expression by 3.7 Ϯ 0.3-fold, (P Ͻ 0.05) in WT-MCT mice and was not reversed in 3M-MCT mice, (Fig. 5, E and F) .
Also, the mRNA expression of Id-1 and Id-3 gene was reduced by 12.1 Ϯ 0.7-fold (P Ͻ 0.05) and 181.4 Ϯ 1.2-fold, respectively, in WT-MCT mice, compared with WT mice. The expression of both Id genes was restored in 3M-MCT mice and showed an increase of 8.28 Ϯ 1.1-fold (P Ͻ 0.05) and 159.4 Ϯ 1.4-fold (P Ͻ 0.001), respectively, compared with the WT-MCT mice (Fig. 5G) . The expression of Id-2 did not change in any treatment group (Fig. 5G) . A representative Western blot analysis showed a 4.9 Ϯ 0.7-fold (P Ͻ 0.05) downregulation of the Id-1 protein in WT-MCT mice, compared with untreated WT mice. The 3M-MCT mice showed an upregulation of Id-1 (5.9 Ϯ 0.6-fold; P Ͻ 0.05), compared with the WT-MCT group (Fig. 5, H and I) .
MCT treatment increases the expression of cell adhesion molecules and inflammatory cytokine expression. The mRNA expression of ICAM-1, VCAM, and PECAM genes was increased by 7.0 Ϯ 2.5-, 126.6 Ϯ 62.4-, and 12.2 Ϯ 2.5-fold (P Ͻ 0.05), respectively, in the RV of WT-MCT mice, compared with untreated WT mice. The 3M-MCT mice showed downregulation of these genes by 3.4 Ϯ 1-, 47.6 Ϯ 8.3-, and 5.4 Ϯ 0.9-fold (P Ͻ 0.05), respectively, compared with WT-MCT group (Fig. 6A) . A representative Western analysis blot showed significant upregulation of ICAM-1 protein by 4.1. Ϯ 0.8-fold (P Ͻ 0.05) in WT-MCT mice, which was downregulated in 3M-MCT-treated mice by 1.9 Ϯ 0.4-fold (P Ͻ 0.05), compared with MCT-treated mice (Fig. 6, B and C) .
The mRNA expression of the proinflammatory cytokine/ chemokine genes, RANTES, IL-6, and CXCL2 was increased by 115.0 Ϯ 26-, 8.2 Ϯ 2.3-, and 7.6 Ϯ 0.7-fold (P Ͻ 0.05), respectively, in the RV of WT-MCT mice, compared with untreated WT mice. The 3M-MCT mice showed a significant downregulation of these molecules (4.6 Ϯ 0.7-, 2.6 Ϯ 0.6-, and 1.7 Ϯ 0.3-fold; P Ͻ 0.05), compared with WT-MCT mice (Fig. 7A) . At the protein level, ELISA results showed upregulation of IL-1␤, IL-6, IFN-␥, and RANTES (11.3 Ϯ 0.25-, 10.7 Ϯ 1.07-, 2.2 Ϯ 0.17-, and 4.8 Ϯ 0.14-fold; P Ͻ 0.05) in WT-MCT mice, compared with WT, and were downregulated in the 3M-MCT group by 1.7 Ϯ 0.25-, 4.8 Ϯ 0.7-, 1.8 Ϯ 0.22-, 2.1 Ϯ 0.32-, and 4.8 Ϯ 0.54-fold, P Ͻ 0.05, respectively, compared with WT-MCT mice. The expression of IL-10 was decreased in WT-MCT mice by 0.6 Ϯ 0.04-fold (P Ͻ 0.05), compared with WT mice and was restored to 2.25 Ϯ 0.43-fold (P Ͻ 0.05) in 3M-MCT mice (Fig. 7B) .
NF-B-regulated genes in RVH induced by MCT: a signaling network.
Based on the results from our study and existing literature available, we propose a signaling network to collate genes and pathway interactions using the candidate genes (Fig. 8) . The in silico analysis using Gene Network Central (GNCPro; Ref. 25) revealed NF-B as central/nodal molecule in the regulation of BMP, TGF, Notch, apoptotic, and Id signaling in WT-MCT mice, indicating a critical involvement of NF-B in PAH-induced RVH (Fig. 8A) . Interestingly, in the 3M-MCT group, when NF-B activation was inhibited (Fig. 8B) , the major molecular interconnections failed. This suggested that NF-B orchestrates various signaling molecules in the setting of PAH-induced RVH remodeling.
DISCUSSION
The important observation of this study is that inhibition of NF-B in 3M mice prevented RVH, despite the presence of PAH. These beneficial effects are associated with significant reduction in NF-B activation, NF-B-targeted genes, restoration of the expression of BMP signaling molecules, and alteration of Notch and Smad signaling molecules. Although the triple mutation in the IB␣ gene has previously been shown to block NF-B activation in the myocardium and to prevent morphological and functional abnormalities in response to multiple stimuli (6) , this is the first report that reveals the functional significance of NF-B in preventing RVH induced by PAH, using a genetic approach. Our study provides important evidence that the Id-BMP-Smad-Notch signaling axis has an important role in RV remodeling in the heart. It is important to mention that the Id-BMP-Smad-Notch axis was restored in the hearts of 3M-MCT mice but not in the lungs, suggesting that although the PAH was not corrected, RVH was prevented. This study provides the following evidences regarding the mechanism of MCT-induced RVH.
First, we showed that MCT treatment induced RVH in WT mice and was associated with an increase in myocytes crosssectional areas. MCT treatment is also known to induce endothelial injury, which may invite infiltrating monocytes and macrophages to invade the subendothelial linings in the RV (20, 28) . Our results are in agreement with these findings wherein we have shown increased nuclei count in the RV of WT-MCT group. We achieved significant reduction in RV mass along with myocytes cross-sectional area that was associated with improved RVH function in 3M-MCT mice, suggesting a positive link between NF-B and RVH. MCT treatment activated the NF-B in the RV and was significantly inhibited in 3M mice treated with MCT. It is noted that the activation of p65 was observed in the nonmyocytes of RV in MCT-treated WT mice. This could be a general inflammatory response caused by MCT treatment that activates NF-B in nonmyocytes as well. However, the activation of NF-B is significantly suppressed in 3M-MCT mice and the effect is associated with reduction in RVH. These results indicate that suppression of NF-B activation in the heart prevents the detrimental morphological and functional changes associated with RVH.
Our data indicate a positive link among NF-B, BMP and Id proteins in PAH-induced RVH. We observed a significant downregulation of BMP-2, BMPR2, and BMR1B in WT-MCT mice, which was restored in 3M-MCT mice, suggesting a link between BMP and NF-B signaling in the RV. Interestingly, NF-B binding sites have been reported in the promoter region of the BMP-2 gene (12) . Increased pulmonary vascular resistance due to vascular remodeling and thrombosis is thought to be a major factor in the development of pathological PAH in humans (18, 53) . The BMPs are a subset of the TGF-␤ superfamily members and function through dimerization of BMPR-1A and BMPR2A receptors. The canonical BMP pathway involved the following three main classes of SMAD and regulates its function via SMAD1, 4, 5, and 8 (16): the receptor-regulated Smads (R-SMAD), which include SMAD1, SMAD2, SMAD3, SMAD5, and SMAD8/9; the commonmediator Smad (co-SMAD), which includes only SMAD4, which interacts with R-SMADs to participate in signaling; and the antagonistic or inhibitory Smads (I-SMAD), which include SMAD6 and SMAD7, which block the activation of R-SMADs and Co-SMADs. In our study, we observed the upregulation of SMAD-4 and downregulation of SMAD 2 and SMAD-8 in the MCT-treated WT animals. These changes were not observed in the 3M mice. Downregulation of BMPRII (Fig. 5D) and SMAD 2 and 8 ( Fig. 5A) complexes indicates that the BMP-TGF␤ canonical signaling pathway is downregulated suggesting that BMP signaling plays a crucial role in PAH. We also observed an increased expression of costimulatory SMAD4 indicating that the upregulation of SMAD4 might be a result of positive feedback signaling for the BMP signaling upon treatment with MCT. There was no change in the expression of SMAD7 in our experimental model indicating that MCTinduced PAH is independent of I-SMAD signaling. Our results are also in agreement with a previous report by Bitzer et al. (3) , which showed that NF-B inhibited TGF-␤ signaling by upregulating Smad7 expression in fibroblasts. On the contrary, a report by Nagarajan et al. (33) showed that NF-B inhibited SMAD signaling independently of Smad7 expression in HEK 293 cells. Consistent with the former observation, our data showed that NF-B downregulated the Smad signaling pathway, independent of Smad7, as we did not observe any alteration of Smad7. Together, our data indicated an association of activated canonical BMP signaling pathways in PAH-induced RVH, which was restored in 3M mice. Collectively, we have provided definitive evidence for cross-talk between TGF-␤/ Smad and NF-B signaling in RVH.
Our study identified an association between NF-B activation and Id proteins. Id proteins have been identified as positive regulators of cell proliferation and negative regulators of cell differentiation. Id proteins are deficient in the DNA binding region but possess a basic helix loop helix (bHLH) dimerization motif and interact with bHLH transcription factors through HLH regions, acting as dominant negative antagonists of bHLH transcription factors (27, 57) . BMP signaling increases the synthesis of Id1, Id2, and Id3 (38) . Our analysis showed a downregulation of both Id1 and Id3 in MCT-treated WT mice, which was restored in 3M mice, indicating a link between NF-B and Id proteins. The mechanism by which NF-B regulates Id proteins remains under investigation. Combined with the BMP signaling data, these findings suggest a functional cross-link between NF-B and BMP-Smad-Id proteins in RVH.
Furthermore, our results demonstrated an involvement of Notch signaling in RV remodeling. We observed a significant upregulation of Notch3 but not Notch1 in the heart of WT-MCT mice, which was prevented in 3M mice, indicating a link between Notch3 and NF-B signaling in RVH. Notch signaling has a significant role in cardiac development, including myocyte differentiation, ventricular trabeculation, valve development (35, 37) , and cellular proliferation and differentiation (1) and recently has been suggested to be a marker for PAH (24) . Our study showed a clear link between NF-B and Notch3 activation in RVH; however, the mechanism whereby NF-B suppression prevents Notch3 expression remains to be elucidated. Although overexpression of Notch3 leads to transactivation of NF-B target promoters, Notch3 might require other coregulators to mediate NF-B activation (2, 39) . Our data are in agreement with the fact that MCT activates NF-B, which in turn promotes Notch activation in RVH.
Our study showed the inhibition of several NF-B-targeted genes in 3M-MCT mice, which were activated in WT-MCT mice. The expression of NF-B target genes depends not only on the activity of NF-B but also the interaction of NF-B with other transcription factors (4, 7, 52) . It will be important to determine the function of these genes in RV remodeling, the findings of which may provide a key to understanding the underlying mechanisms of PAH-induced RVH and subsequent RV failure.
Our study indicated that MCT induces proinflammatory reaction and invites leucocyte infiltration, which may play a critical role in the pathogenesis of PAH mediated RVH. Upregulation and increased production of cytokines represent an intrinsic or innate stress response against cell injury in PAH (36) . In this study, we found that RANTES and IL-6 levels were decreased in 3M-MCT mice hearts, compared with WT-MCT, suggesting that NF-B inhibition is associated with the inflammatory response. One possible mechanism for such a protective effect relates to the presence of the B-binding element in the promoter region. We observed a significant downregulation of adhesion molecules, including ICAM-1, PECAM, and VCAM. These genes do not have NF-B DNA binding sites in the proximal promoters, except for ICAM-1 (55) . Reduction of the expression of these genes is more likely to be an indirect effect or could be mediated by the interaction of other transcription factors. Finally, we showed a significant alteration in the expression of apoptotic genes in 3M-MCT mice. Apoptosis is an important phenomenon associated with end stage heart failure (23, 29, 34) . This is a highly organized and regulated process, wherein cell death follows a genetically determined program mediated by caspase-dependent protein cleavage and DNA laddering or fragmentation (15) . NF-B inhibition prevented RVH in 3M mice and was associated with upregulation of Bcl 2 (anti-apoptotic gene) and downregulation of Bax (proapoptotic gene), suggesting that NF-B has an important role in regulating programmed cell death in PAHinduced RVH.
In this report, we studied the functional significance of NF-B inhibition using triple mutation in the IB␣ gene in the heart in a MCT-induced PAH-mediated RVH model. We tried to focus on the important mechanisms that are believed to play a crucial role in RVH. These include the apoptotic pathways, Notch signaling, BMP-SMAD-Id signaling, inflammatory cytokines, and adhesion molecules. It is possible that the changes presented in the present study represent results and, not the cause of RVH, which is a limitation. Nevertheless, our study provides important evidence that the Id-BMP-Smad-Notch signaling axis may have an important role in RV remodeling in the heart, which was restored in hearts of 3M-MCT mice but not in the lungs, suggesting that although the PAH was not corrected, RVH was prevented. Future studies to determine which NF-B-dependent signaling pathways play direct functional roles in these responses are now possible, because of this work.
In conclusion, our study suggests that despite the presence of PAH, RVH is prevented in 3M mice, indicating a potential role of NF-B in RV remodeling. The study identifies the importance of cross-talk between the Id-BMP-Smad-Notch gene axis and NF-B signaling, providing new mechanistic information in PAH-induced RVH regulation. Further research into understanding the critical NF-B-dependent pathways in RVH may illuminate even more direct targets for therapy.
